Grupo Televisa, S.A.B. (TV) Analysts See $0.06 EPS; Quotient Ltd (QTNT)’s Sentiment Is 1.93

April 24, 2018 - By wolcottdaily

Quotient Limited (NASDAQ:QTNT) Logo

Quotient Ltd (QTNT) investors sentiment increased to 1.93 in 2017 Q4. It’s up 0.51, from 1.42 in 2017Q3. The ratio has increased, as 29 investment managers increased and started new holdings, while 15 decreased and sold their equity positions in Quotient Ltd. The investment managers in our database now have: 30.23 million shares, up from 21.37 million shares in 2017Q3. Also, the number of investment managers holding Quotient Ltd in top ten holdings decreased from 2 to 1 for a decrease of 1. Sold All: 5 Reduced: 10 Increased: 22 New Position: 7.

Analysts expect Grupo Televisa, S.A.B. (NYSE:TV) to report $0.06 EPS on April, 25.They anticipate $0.06 EPS change or 50.00% from last quarter’s $0.12 EPS. TV’s profit would be $35.30 million giving it 73.25 P/E if the $0.06 EPS is correct. After having $0.05 EPS previously, Grupo Televisa, S.A.B.’s analysts see 20.00% EPS growth. The stock decreased 0.73% or $0.13 during the last trading session, reaching $17.58. About 1.35M shares traded. Grupo Televisa, S.A.B. (NYSE:TV) has declined 39.94% since April 24, 2017 and is downtrending. It has underperformed by 51.49% the S&P500.

The stock decreased 9.30% or $0.41 during the last trading session, reaching $4. About 318,028 shares traded. Quotient Limited (QTNT) has declined 24.44% since April 24, 2017 and is downtrending. It has underperformed by 35.99% the S&P500.

Analysts await Quotient Limited (NASDAQ:QTNT) to report earnings on May, 28. They expect $-0.51 EPS, up 26.09% or $0.18 from last year’s $-0.69 per share. After $-0.47 actual EPS reported by Quotient Limited for the previous quarter, Wall Street now forecasts 8.51% negative EPS growth.

Quotient Limited, a commercial-stage diagnostics company, develops, makes, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company has market cap of $182.35 million. The firm is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening. It currently has negative earnings. It also develops, makes, and commercializes conventional reagent products for blood grouping, including antisera products that are used to identify blood-group antigens; reagent red blood cells, which enable the identification of blood-group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping.

Sio Capital Management Llc holds 3.98% of its portfolio in Quotient Limited for 1.43 million shares. Cormorant Asset Management Llc owns 4.49 million shares or 2.33% of their US portfolio. Moreover, Perceptive Advisors Llc has 0.98% invested in the company for 6.03 million shares. The Maryland-based Clearbridge Llc has invested 0.26% in the stock. Polar Capital Llp, a United Kingdom-based fund reported 6.80 million shares.

Since January 1, 0001, it had 1 insider buy, and 0 insider sales for $51,348 activity.

Grupo Televisa, S.A.B. (NYSE:TV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.